SC Filed 2019-03-19 Event — SEC 0000903423-19-000150 →

VIKING GLOBAL INVESTORS LP → Axovant Sciences Ltd.

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

16 13D/G filings on this issuer

15 other filings besides this one

Filer Track Record

13 filings by this filer

12 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other 13D/G Filings on Axovant Sciences Ltd.

Filed	Form	Filer	Stake	Shares
2019-12-31	SC	Roivant Sciences Ltd.	—	—	view →
2019-07-17	SC	Lo Andrew	—	—	view →
2019-07-16	SC	Machado Patrick	—	—	view →
2019-07-16	SC	Roivant Sciences Ltd.	—	—	view →
2019-07-12	SC	VIKING GLOBAL INVESTORS LP	—	—	view →
2019-07-12	SC	Dexxon Holdings Ltd.	—	—	view →
2019-07-12	SC	QVT Financial LP	—	—	view →
2019-07-12	SC	SVF Investments (UK) Ltd	—	—	view →
2019-03-19	SC	Machado Patrick	—	—	view →
2019-03-19	SC	Roivant Sciences Ltd.	—	—	view →
2019-03-19	SC	QVT Financial LP	—	—	view →
2019-03-19	SC	Dexxon Holdings Ltd.	—	—	view →
2019-03-19	SC	Lo Andrew	—	—	view →
2019-03-19	SC	SVF Investments (UK) Ltd	—	—	view →
2019-01-03	SC	VIKING GLOBAL INVESTORS LP	—	—	view →

Other Filings by VIKING GLOBAL INVESTORS LP

Filed	Form	Issuer	Stake	Shares
2026-04-02	SCHEDULE 13D/A	BridgeBio Pharma, Inc. BBIO	6.10%	11,842,434	view →
2025-07-01	SCHEDULE	BridgeBio Pharma, Inc. BBIO	9.80%	18,602,920	view →
2025-01-31	SCHEDULE	BridgeBio Pharma, Inc. BBIO	11.70%	22,055,375	view →
2021-10-01	SC	Ginkgo Bioworks Holdings, Inc. DNABW	—	—	view →
2019-07-12	SC	Myovant Sciences Ltd.	—	—	view →
2019-07-12	SC	Axovant Gene Therapies Ltd.	—	—	view →
2019-07-12	SC	Urovant Sciences Ltd.	—	—	view →
2019-07-12	SC	Arbutus Biopharma Corp ABUS	—	—	view →
2019-01-03	SC	Arbutus Biopharma Corp ABUS	—	—	view →
2019-01-03	SC	Urovant Sciences Ltd.	—	—	view →
2019-01-03	SC	Axovant Sciences Ltd.	—	—	view →
2018-01-16	SC	Arbutus Biopharma Corp ABUS	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →